These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25365592)

  • 1. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.
    Prescott LS; Kidin LM; Downs RL; Cleveland DJ; Wilson GL; Munsell MF; DeJesus AY; Cain KE; Ramirez PT; Kroll MH; Levenback CF; Schmeler KM
    Int J Gynecol Cancer; 2015 Jan; 25(1):152-9. PubMed ID: 25365592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
    Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
    JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quality improvement initiative to reduce venous thromboembolism on a gynecologic oncology service.
    Gonzalez R; Kurtovic K; Habib AS; Ryan ES; Foote J; Pandya D; Broadwater G; Havrilesky LJ
    Gynecol Oncol; 2021 Jul; 162(1):120-127. PubMed ID: 33994013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.
    Haut ER; Lau BD; Kraenzlin FS; Hobson DB; Kraus PS; Carolan HT; Haider AH; Holzmueller CG; Efron DT; Pronovost PJ; Streiff MB
    Arch Surg; 2012 Oct; 147(10):901-7. PubMed ID: 23070407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Electronic Alert System Is Associated With a Significant Increase in Pharmacologic Venous Thromboembolism Prophylaxis Rates Among Hospitalized Inflammatory Bowel Disease Patients.
    Mathers B; Williams E; Bedi G; Messaris E; Tinsley A
    J Healthc Qual; 2017; 39(5):307-314. PubMed ID: 27153049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based venous thromboembolism prophylaxis is associated with a six-fold decrease in numbers of symptomatic venous thromboembolisms in rehabilitation inpatients.
    Mayer RS; Streiff MB; Hobson DB; Halpert DE; Berenholtz SM
    PM R; 2011 Dec; 3(12):1111-1115.e1. PubMed ID: 22192320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies.
    Schmeler KM; Wilson GL; Cain K; Munsell MF; Ramirez PT; Soliman PT; Nick AM; Frumovitz M; Coleman RL; Kroll MH; Levenback CF
    Gynecol Oncol; 2013 Feb; 128(2):204-8. PubMed ID: 23200912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a venous thromboembolism prophylaxis program for hospitalized patients.
    Cardoso LF; Krokoscz DV; de Paiva EF; Furtado IS; Mattar J; de Souza E Sá MM; de Lira AC
    Vasc Health Risk Manag; 2016; 12():491-496. PubMed ID: 28003757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a mandated venous thromboembolism clinical order set improves venous thromboembolism core measures.
    Khoury L; Dangodara AA; Lee JA; Lovejoy M; Amin AN
    Hosp Pract (1995); 2014 Dec; 42(5):89-99. PubMed ID: 25485921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma.
    Baz R; Furman R; Simondsen K; Stone C
    Cancer Control; 2020; 27(2):1073274820930204. PubMed ID: 32551873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events.
    Zeidan AM; Streiff MB; Lau BD; Ahmed SR; Kraus PS; Hobson DB; Carolan H; Lambrianidi C; Horn PB; Shermock KM; Tinoco G; Siddiqui S; Haut ER
    Am J Hematol; 2013 Jul; 88(7):545-9. PubMed ID: 23553743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary, patient-centred approach to improving compliance with venous thromboembolism (VTE) prophylaxis in a district general hospital.
    Nana M; Shute C; Williams R; Kokwaro F; Riddick K; Lane H
    BMJ Open Qual; 2020 Jul; 9(3):. PubMed ID: 32718914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean section.
    Pon TK; Wessel N; Cagonot V; Delmonte R; Roach D; Finta L
    Int J Clin Pharm; 2019 Feb; 41(1):264-271. PubMed ID: 30661217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliminating Health Care Disparities With Mandatory Clinical Decision Support: The Venous Thromboembolism (VTE) Example.
    Lau BD; Haider AH; Streiff MB; Lehmann CU; Kraus PS; Hobson DB; Kraenzlin FS; Zeidan AM; Pronovost PJ; Haut ER
    Med Care; 2015 Jan; 53(1):18-24. PubMed ID: 25373403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
    Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
    Brown A
    Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects in Processes of Care for Pharmacologic Prophylaxis Are Common Among Neurosurgery Patients Who Develop In-Hospital Postoperative Venous Thromboembolism.
    Yun R; Sciubba DM; Lewin JJ; Streiff MB; Haut ER; Lau BD; Shermock KM; Kraus PS; Popoola VO; Dalpoas SE
    World Neurosurg; 2020 Feb; 134():e664-e671. PubMed ID: 31698120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.
    Kociol RD; Hammill BG; Hernandez AF; Klaskala W; Mills RM; Curtis LH; Fonarow GC
    Clin Cardiol; 2011 Nov; 34(11):682-8. PubMed ID: 22057910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple reminder system improves venous thromboembolism prophylaxis rates and reduces thrombotic events for hospitalized patients1.
    Mitchell JD; Collen JF; Petteys S; Holley AB
    J Thromb Haemost; 2012 Feb; 10(2):236-43. PubMed ID: 22188121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.